Nur Nicholson's most recent trade in Apellis Pharmaceuticals Inc was a trade of 82,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 82,500 | 82,500 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 29.52 per share. | 29 Jan 2025 | 825 | 83,664 (0%) | 0% | 29.5 | 24,357 | Common Stock |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 30.43 per share. | 22 Jan 2025 | 3,948 | 84,489 (0%) | 0% | 30.4 | 120,120 | Common Stock |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 36,426 | 88,437 (0%) | 0% | 0 | Common Stock | |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 29.96 per share. | 17 Jan 2025 | 2,145 | 52,011 (0%) | 0% | 30.0 | 64,260 | Common Stock |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 28.70 per share. | 13 Jan 2025 | 2,632 | 54,156 (0%) | 0% | 28.7 | 75,544 | Common Stock |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 57.31 per share. | 13 Mar 2024 | 7,768 | 59,739 (0%) | 0% | 57.3 | 445,161 | Common Stock |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 58.13 per share. | 13 Mar 2024 | 3,452 | 56,287 (0%) | 0% | 58.1 | 200,677 | Common Stock |
| Apellis Pharmaceuticals Inc | Nicholson Nur | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 64.14 per share. | 29 Jan 2024 | 835 | 67,507 (0%) | 0% | 64.1 | 53,555 | Common Stock |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 65.00 per share. | 22 Jan 2024 | 2,593 | 68,342 (0%) | 0% | 65.0 | 168,535 | Common Stock |
| Apellis Pharmaceuticals Inc | Nicholson Nur | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 28,367 | 28,367 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Nicholson Nur | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 19,508 | 72,792 (0%) | 0% | 0 | Common Stock | |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 66.81 per share. | 16 Jan 2024 | 1,857 | 70,935 (0%) | 0% | 66.8 | 124,064 | Common Stock |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 14,023 | 14,023 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 9,886 | 64,328 (0%) | 0% | 0 | Common Stock | |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.50 per share. | 21 Feb 2023 | 825 | 63,503 (0%) | 0% | 58.5 | 48,263 | Common Stock |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.77 per share. | 27 Jan 2023 | 551 | 54,442 (0%) | 0% | 52.8 | 29,076 | Common Stock |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.05 per share. | 20 Jan 2023 | 2,034 | 54,993 (0%) | 0% | 52.1 | 105,870 | Common Stock |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2022 | 35,472 | 35,472 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2022 | 22,580 | 57,027 (0%) | 0% | 0 | Common Stock | |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Other type of transaction at price $ 0.00 per share. | 25 Apr 2022 | 11,250 | 0 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Other type of transaction at price $ 0.00 per share. | 25 Apr 2022 | 1,875 | 33,680 (0%) | 0% | 0 | Common Stock | |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.59 per share. | 28 Jan 2022 | 650 | 35,555 (0%) | 0% | 38.6 | 25,084 | Common Stock |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2022 | 36,951 | 36,951 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2022 | 26,051 | 36,205 (0%) | 0% | 0 | Common Stock | |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 11,250 | 11,250 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 7,500 | 7,500 (0%) | 0% | 0 | Common Stock | |
| Apellis Pharmaceuticals Inc | Nur Nicholson | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 1,875 | 9,375 (0%) | 0% | 0 | Common Stock |